A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies
Clinical trial NCT04606381 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04606381
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-10
- Primary completion
- 2024-07-11
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.